Below are the most recent publications written about "Oligonucleotides" by people in Profiles.
-
Lee JK, Lee HN, Agrawal S, Balsamo JA, Clerman A, Denies S, De Groot A, Fry J, Gaudenzio N, Graves AJ, Howard KE, Hwang S, Jawa V, Jin Y, Kelly-Baker L, Knowlton E, Kolenc F, Sivakumar KK, Lee JH, Li Y, Liang L, Liu D, Liu Y, Lionberger R, Luke MC, Manangeeswaran M, Mendoza M, Murphy I, Norcross M, Polli JE, Puig M, Rao Sp N, Rogers H, Schwendeman A, Siegel R, Shubow S, Smith N, Thacker SG, Tourdot S, Yang K, Zhang L, Zhang D, Smith CJ, Pang ES, Verthelyi D. Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products. AAPS J. 2026 Feb 12; 28(2):61.
-
Agrawal S. Transient Cyclic Structured Oligonucleotide Designs for Therapeutic Applications. Curr Protoc. 2026 Feb; 6(2):e70319.
-
David SS, Pacheco BA, Kishimoto K, Vantine S, Hu K, Liu H, Davis DL, Tran H, Sallis BF, Ali L, Haynes CM, McCormick BA, Zhu LJ, Flavahan WA. Multidimensional third-generation sequencing of modified DNA bases allows interrogation of complex biological systems. Nat Commun. 2025 Jul 01; 16(1):5676.
-
O'Reilly D, Furgal R, Hariharan V, Lochmann C, Cooper D, Echeverria D, Khvorova A. Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs. Nucleic Acid Ther. 2025 Jun; 35(3):137-149.
-
Shneider NA, Harms MB, Korobeynikov VA, Rifai OM, Hoover BN, Harrington EA, Aziz-Zaman S, Singleton J, Jamil A, Madan VR, Lee I, Andrews JA, Smiley RM, Alam MM, Black LE, Shin M, Watts JK, Walk D, Newman D, Pascuzzi RM, Weber M, Neuwirth C, Da Cruz S, Soriano A, Lane R, Henry S, Mathews J, Jafar-Nejad P, Norris D, Rigo F, Brown RH, Miller S, Crean R, Bennett CF. Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series. Lancet. 2025 Jun 07; 405(10494):2075-2086.
-
Hedger AK, Myint W, Lee JM, Suchenski Loustaunau D, Balachandran V, Shaqra AM, Kurt Yilmaz N, Watts JK, Matsuo H, Schiffer CA. Next generation?APOBEC3 inhibitors: optimally designed for potency and nuclease stability. Nucleic Acids Res. 2025 Mar 20; 53(6).
-
Matesanz SE, Brigatti KW, Young M, Yum SW, Strauss KA. Preemptive dual therapy for children at risk for infantile-onset spinal muscular atrophy. Ann Clin Transl Neurol. 2024 Jul; 11(7):1868-1878.
-
Agrawal S. Considerations for Creating the Next Generation of RNA Therapeutics: Oligonucleotide Chemistry and Innate Immune Responses to Nucleic Acids. Nucleic Acid Ther. 2024 04; 34(2):37-51.
-
Zhang H, Kelly K, Lee J, Echeverria D, Cooper D, Panwala R, Amrani N, Chen Z, Gaston N, Wagh A, Newby GA, Xie J, Liu DR, Gao G, Wolfe SA, Khvorova A, Watts JK, Sontheimer EJ. Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo. Nucleic Acids Res. 2024 Jan 25; 52(2):977-997.
-
Sharma VK, Mangla P, Singh SK, Prasad AK. Triazole-linked Nucleic Acids: Synthesis, Therapeutics and Synthetic Biology Applications. Curr Org Synth. 2024; 21(4):436-455.